Target Healthcare REIT(GB:THRL)
GBXÂ 118.40-1.40 (-1.33%)
GB:THRL
Target Healthcare REIT financials statements
GBXÂ 118.40
At close:-1.40 (-1.33%)
Want to see GB:THRL full AI Analyst Report?
Target Healthcare REIT (THRL) Ratios
42 Followers
Target Healthcare REIT Ratios
GB:THRL's free cash flow for Q4 2025 was £0.00. For the 2025 fiscal year, GB:THRL's free cash flow was decreased by £-20.59M and operating cash flow was £20.59M. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.38 | 1.43 | 7.78 | 4.02 | 9.43 |
| Quick Ratio | 7.38 | 1.43 | 1.17 | 4.02 | 9.43 |
| Cash Ratio | 2.41 | 0.43 | 2.11 | 4.45 | 9.30 |
| Solvency Ratio | 0.36 | 0.22 | 0.26 | -0.25 | -0.00 |
| Operating Cash Flow Ratio | 2.12 | 0.45 | 2.29 | 7.75 | 8.31 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.45 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | £ -75.90M | £ -142.33M | £ -134.32M | £ -238.08M | £ -230.41M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.24 | 0.25 | 0.25 | 0.24 |
| Debt-to-Equity Ratio | 0.26 | 0.34 | 0.35 | 0.35 | 0.33 |
| Debt-to-Capital Ratio | 0.21 | 0.25 | 0.26 | 0.26 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.21 | 0.17 | 0.26 | 0.26 | 0.25 |
| Financial Leverage Ratio | 1.31 | 1.38 | 1.40 | 1.39 | 1.38 |
| Debt Service Coverage Ratio | 9.59 | 0.58 | 5.66 | 0.00 | -0.00 |
| Interest Coverage Ratio | 6.34 | 5.20 | 7.13 | 6.37 | 8.22 |
| Debt to Market Cap | 0.29 | 0.37 | 0.49 | 0.51 | 0.36 |
| Interest Debt Per Share | 0.33 | 0.41 | 0.40 | 0.38 | 0.40 |
| Net Debt to EBITDA | 1.59 | 3.37 | 3.48 | 0.00 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 88.04% | 88.92% | 100.00% | 88.77% | 88.56% |
| EBIT Margin | 127.94% | 81.71% | 73.90% | 84.15% | 78.54% |
| EBITDA Margin | 127.94% | 81.71% | 73.90% | 0.00% | 0.00% |
| Operating Profit Margin | 84.54% | 81.71% | 93.05% | 84.15% | 78.54% |
| Pretax Profit Margin | 114.60% | 83.43% | 93.05% | -9.70% | 76.89% |
| Net Profit Margin | 114.60% | 83.43% | 93.05% | -9.70% | 76.88% |
| Continuous Operations Profit Margin | 114.60% | 83.43% | 93.05% | -9.70% | 76.88% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 99.99% |
| EBT Per EBIT | 135.56% | 102.10% | 100.00% | -11.53% | 97.90% |
| Return on Assets (ROA) | 8.35% | 6.17% | 7.55% | -0.72% | 5.09% |
| Return on Equity (ROE) | 10.90% | 8.54% | 10.59% | -1.00% | 7.03% |
| Return on Capital Employed (ROCE) | 6.29% | 6.66% | 7.70% | 6.30% | 5.22% |
| Return on Invested Capital (ROIC) | 6.29% | 6.04% | 57.00% | 7.02% | 5.64% |
| Return on Tangible Assets | 8.35% | 6.17% | 7.55% | -0.72% | 5.09% |
| Earnings Yield | 12.28% | 9.41% | 15.02% | -1.48% | 7.56% |
| Efficiency Ratios | |||||
| Receivables Turnover | 152.04 | 0.79 | 0.83 | 0.95 | 1.05 |
| Payables Turnover | 2.63 | 0.00 | 3.39 | 3.82 | 4.15 |
| Inventory Turnover | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.08 | 0.07 |
| Asset Turnover | 0.07 | 0.07 | 0.08 | 0.07 | 0.07 |
| Working Capital Turnover Ratio | 0.83 | 0.88 | 1.15 | 3.20 | 2.67 |
| Cash Conversion Cycle | -136.42 | 459.25 | 6109.56 | 288.84 | 258.91 |
| Days of Sales Outstanding | 2.40 | 459.25 | 437.61 | 384.38 | 346.93 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 5779.55 | 0.00 | 0.00 |
| Days of Payables Outstanding | 138.82 | 0.00 | 107.60 | 95.54 | 88.02 |
| Operating Cycle | 2.40 | 459.25 | 6217.16 | 384.38 | 346.93 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.07 | 0.07 | 0.07 | 0.05 | 0.05 |
| Free Cash Flow Per Share | 0.00 | 0.07 | 0.07 | 0.05 | 0.05 |
| Dividend Paid and CapEx Coverage Ratio | 0.55 | 1.14 | 1.20 | 0.74 | 0.76 |
| Capital Expenditure Coverage Ratio | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.23 | 0.17 | 0.18 | 0.13 | 0.13 |
| Operating Cash Flow to Sales Ratio | 0.62 | 0.56 | 0.54 | 0.44 | 0.48 |
| Free Cash Flow Yield | 0.00% | 6.36% | 8.71% | 6.66% | 4.68% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 8.34 | 10.62 | 6.66 | -67.76 | 13.23 |
| Price-to-Sales (P/S) Ratio | 9.33 | 8.86 | 6.20 | 6.57 | 10.17 |
| Price-to-Book (P/B) Ratio | 0.89 | 0.91 | 0.71 | 0.68 | 0.93 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | 15.72 | 11.48 | 15.01 | 21.37 |
| Price-to-Operating Cash Flow Ratio | 15.02 | 15.72 | 11.48 | 15.01 | 21.37 |
| Price-to-Earnings Growth (PEG) Ratio | 0.26 | -0.58 | -0.01 | 0.60 | -1.19 |
| Enterprise Value Multiple | 8.88 | 14.21 | 11.86 | 0.00 | 0.00 |
| Enterprise Value | 819.20M | 847.05M | 688.05M | 655.34M | 846.78M |
| EV to EBITDA | 8.88 | 14.21 | 11.86 | 0.00 | 0.00 |
| EV to Sales | 11.37 | 11.61 | 8.77 | 9.67 | 13.26 |
| EV to Free Cash Flow | 0.00 | 20.61 | 16.25 | 22.09 | 27.86 |
| EV to Operating Cash Flow | 18.30 | 20.61 | 16.25 | 22.09 | 27.86 |
| Tangible Book Value Per Share | 1.22 | 1.15 | 1.11 | 1.06 | 1.17 |
| Shareholders’ Equity Per Share | 1.22 | 1.15 | 1.11 | 1.06 | 1.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.12 | 0.12 | 0.13 | 0.11 | 0.11 |
| Net Income Per Share | 0.13 | 0.10 | 0.12 | -0.01 | 0.08 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.90 | 1.02 | 1.26 | -0.12 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.03 | 0.04 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.54 | 0.68 | 0.58 | -4.51 | 0.62 |
Currency in GBP
